ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
67.37
-0.24 (-0.35%)
Mar 31, 2025, 3:37 PM EDT - Market open

Company Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.

It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.

It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals logo
Country United States
Founded 2001
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 897
CEO Nikhil Lalwani

Contact Details

Address:
210 Main Street West
Baudette, Minnesota 56623
United States
Phone 218 634 3500
Website anipharmaceuticals.com

Stock Details

Ticker Symbol ANIP
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001023024
CUSIP Number 00182C103
ISIN Number US00182C1036
Employer ID 58-2301143
SIC Code 2834

Key Executives

Name Position
Nikhil Lalwani President, Chief Executive Officer and Director
Stephen P. Carey Senior Vice President of Finance and Chief Financial Officer
Chad Gassert Senior Vice President of Corporate Development and Strategy
Christopher K. Mutz Senior Vice President and Head of Rare Disease
Ori Gutwerg Senior Vice President of Generics
Muthusamy Shanmugam MS R.Ph. Head of Research & Development, Chief Operating Officer of New Jersey Operations and Director
Elizabeth Powell J.D. Chief Compliance Officer and Head of Legal of Rare Disease
Meredith W. Cook J.D. Senior Vice President, General Counsel and Corporate Secretary
Krista L. Davis Senior Vice President and Chief Human Resources Officer
Dr. Mary Pao M.D., Ph.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Mar 18, 2025 8-K Current Report
Mar 14, 2025 8-K Current Report
Mar 13, 2025 SCHEDULE 13D/A Filing
Mar 11, 2025 8-K Current Report
Feb 28, 2025 10-K Annual Report
Feb 28, 2025 8-K Current Report
Feb 5, 2025 8-K Current Report
Jan 21, 2025 SCHEDULE 13G Filing
Jan 13, 2025 8-K Current Report
Dec 17, 2024 144 Filing